Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
accuracy, alive, Altera, Alton, Andrew, appointed, appointment, armed, autotaxin, banc, Bausch, behalf, Bio, Breakthrough, Brett, bribery, cardiopulmonary, Carna, CCPA, Christi, Cipla, collateralized, Commissioner, confer, consent, contrary, culture, Delinquent, denial, Dickinson, disagree, dramatically, durable, Eisai, Elipovimab, employer, en, encourage, exit, expropriation, facilitate, flooding, Florida, footnote, Glympse, Goldfinch, Gregg, guideline, heavily, Hoofddorp, HPV, Humanigen, implicit, incremental, iNHL, injury, Insitro, instability, Irish, Johanna, Jyoti, Katie, Kiniksa, Korea, Korean, Kyverna, Lake, lenalidomide, lengthy, Lichtenstein, Lyndra, McHutchison, MCL, Mehra, Mercier, Merdad, NaN, nationwide, Nordisk, Notwithstanding, Novo, Nurix, organizational, Parsey, permanent, Pletcher, pre, prevailed, put, quantitative, RA, recoup, Renown, resold, restate, Robin, Rockefeller, Selgantolimod, Shaw, Shilpa, shorter, specialist, stand, standstill, statutorily, STELLAR, subscription, Sunshine, suspension, taxpayer, terrorism, terrorist, theft, Topline, unrest, upper, variety, Vice, voluntarily, war, Yuhan
Removed:
accrual, Actelion, ADAP, affirmed, aged, Alberta, Apollo, bank, biliary, broker, BTK, burdensome, calcium, calendar, canceled, carboxylase, carcinoma, cardiovascular, ceiling, centralized, characteristic, contacted, conversion, decentralized, decide, declaratory, deduction, discipline, dismissed, distinct, dosage, earning, Ebola, Egypt, embrace, expending, Eyetech, factor, floating, French, German, GlaxoSmithKline, Greece, hepatocellular, improvement, India, integral, invoiced, Iran, JT, labeled, maker, mutual, Mylan, nominee, noncurrent, nonrecurring, Nuc, obligated, perspective, Pfizer, pharmacy, plasma, Portugal, predominantly, principle, promised, recognizing, recover, reducing, refuse, relation, relevance, renew, rental, reserve, resolve, response, revoke, ruled, significance, simplified, Simplifying, staying, suggest, Syk, targeted, terminating, unclean, uncollectible, unenforceable, Virginia, West, whichever, wide, withdrawn
Filing tables
Filing exhibits
- 10-K Annual report
- 4.9 Description of Registrant's Securities
- 10.28 Offer Letter (Hamill)
- 10.29 Severance Agreement (Hamill)
- 21.1 Listing of Subsidiaries
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 CEO Certification
- 31.2 CFO Certification
- 32 Section 906 Certifications
- Download Excel data file
- View Excel data file
Related press release
Associated GILD transcripts
GILD similar filings
Filing view
External links
Exhibit 32
CERTIFICATIONS
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. § 1350, as adopted), Daniel P. O’Day, the Chairman and Chief Executive Officer of Gilead Sciences, Inc. (the Company), and Andrew D. Dickinson, the Executive Vice President and Chief Financial Officer of the Company, each hereby certifies that, to the best of his or her knowledge:
1. The Company’s Annual Report on Form 10-K for the annual period ended December 31, 2019 (the Report) fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: February 24, 2020
/s/ DANIEL P. O’DAY | /s/ ANDREW D. DICKINSON | |
Daniel P. O’Day Chairman and Chief Executive Officer | Andrew D. Dickinson Executive Vice President and Chief Financial Officer |
This certification accompanies the Form 10-K to which it relates, is not deemed filed with the SEC and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, (whether made before or after the date of the Form 10-K), irrespective of any general incorporation language contained in such filing.